Join or Renew Now!
AAPS esubscriber: the first and only online subscription for pharmaceutical scientists.
Imagine a place where you stay informed, make new professional contacts, advance your career, and save money—all at the click of a button. As an AAPS esubscriber, you'll find substantive scientific resources, products, and services on AAPS' Web site. For only $65 a year, you’ll enjoy most of the online privileges that AAPS regular members receive.
As a foremost international, interdisciplinary community of pharmaceutical scientists, AAPS membership puts you at the center of it all and gives you the access to people, information, and opportunities that will strengthen your career—and it’s just a couple of clicks away.
The AAPS Newsmagazine is the most respected source for industry insight and association news for the world’s leading pharmaceutical scientists. Feature topics include drug delivery systems, the use of technology, regulatory agencies’ activities, and industry modernization.
Portable, interactive, and easily accessible from the nearest computer, the AAPS Newsmagazine digital edition delivers your content—including digital edition-only content—in a timely manner; allows you to search the entire issue; offers you the capabilities to email an article or the entire issue to your friends and colleagues; and provides you links to connect directly to company Web pages.
Official AAPS Journals
You will have full online access to www.pharmagateway.net, where you may explore the three official AAPS journals—The AAPS Journal, AAPS PharmSciTech, and Pharmaceutical Research. Published in conjunction with Springer, these journals are vital to the pharmaceutical sciences.
The AAPS Journal is an online-only journal publishing peer-reviewed scholarly reviews, themed issues, and research articles within the entire scope of the pharmaceutical sciences encompassed by the AAPS membership. The journal particularly aims to foster the dissemination of scientific information presented at AAPS-sponsored meetings, workshops, and symposia through the publication of invited reviews in themed issues.
AAPS PharmSciTech is an online-only journal committed to serving those pharmaceutical scientists and engineers interested in the research, development, and evaluation of pharmaceutical dosage forms, including drugs derived from biotechnology and the manufacturing science pertaining to the commercialization of such dosage forms. Because of its electronic nature, AAPS PharmSciTech aspires to utilize evolving electronic technology to enable faster and diverse mechanisms of information delivery to its readership.
Pharmaceutical Research, an official AAPS journal, publishes papers on innovative research spanning the entire spectrum of science that is the foundation of drug discovery, development, evaluation, and regulatory approval. Small drug molecules; biotechnology products including genes, peptides, proteins and vaccines; and genetically engineered cells are integral parts of papers published in Pharmaceutical Research.
Career Network and Online Education
As an esubscriber, you will also have access to the AAPS Online Career Center. The online career center allows you to view new job postings, submit your résumé online, access the updated Salary Survey, or investigate internship opportunities. Regardless of your level of achievement in the pharmaceutical sciences, AAPS provides numerous opportunities for your to further your career.
Esubscriber access is also a beneficial learning tool; AAPS offers numerous elearning programs that allow you to enhance your professional development from the comfort of your home or office. eSubscribers receive free access to archived AAPS webinars and can access recorded live AAPS webinars after a thirty day embargo.
Join now as an esubscriber.
*Note: AAPS esubscribers enjoy full online privileges of AAPS members. However, esubscribers are ineligible for conference/meeting discounts and do not possess full voting rights in the Association. Also, esubscribers receive free access to archived AAPS webinars and can access recorded live AAPS webinars after a thirty day embargo.